Neurocrine Biosciences
NBIX
#1291
Rank
HK$107.35 B
Marketcap
HK$1,060
Share price
-0.34%
Change (1 day)
3.49%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of September 2024 : HK$9.53 Billion

According to Neurocrine Biosciences 's latest financial reports the company has HK$9.53 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$8.05 B4.23%
2022-12-31HK$7.72 B39.36%
2021-12-31HK$5.54 B-10.68%
2020-12-31HK$6.20 B18.91%
2019-12-31HK$5.22 B2.45%
2018-12-31HK$5.09 B26.45%
2017-12-31HK$4.03 B69.13%
2016-12-31HK$2.38 B-18.91%
2015-12-31HK$2.93 B95.51%
2014-12-31HK$1.50 B33.02%
2013-12-31HK$1.13 B-15.73%
2012-12-31HK$1.34 B33.74%
2011-12-31HK$1.00 B1.56%
2010-12-31HK$0.98 B138.16%
2009-12-31HK$0.41 B-33.34%
2008-12-31HK$0.62 B-55.54%
2007-12-31HK$1.39 B-1.52%
2006-12-31HK$1.42 B-32.92%
2005-12-31HK$2.11 B-9.53%
2004-12-31HK$2.34 B-33.38%
2003-12-31HK$3.51 B84.06%
2002-12-31HK$1.90 B-23.51%
2001-12-31HK$2.49 B94.27%
2000-12-31HK$1.28 B81.47%
1999-12-31HK$0.70 B680.77%
1998-12-31HK$90.64 M-25.97%
1997-12-31HK$0.12 B40.09%
1996-12-31HK$87.4 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$6.08 B-36.16%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$13.70 B 43.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$18.51 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.32 B 186.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$56.57 B 493.24%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$77.29 B 710.42%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.19 B-87.52%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$7.92 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA